Human submandibular saliva inhibits human immunodeficiency virus type 1 infection by displacing envelope glycoprotein gp120 from the virus

Thandavarayan Nagashunmugam, Daniel Malamud, Cheryl Davis, William R. Abrams, Harvey M. Friedman

Research output: Contribution to journalArticle

Abstract

Human submandibular saliva reduces human immunodeficiency virus type 1 (HIV-1) infection in vitro. To define the mechanism of inhibition, virus was incubated with saliva or medium, velocity sucrose gradient centrifugation was performed, and fractions were analyzed for p24 and gp120. The results show that after incubation with saliva, the envelope glycoprotein was displaced from both a laboratory-adapted and a low-passage clinical HIV-1 isolate. To identify the salivary protein(s) responsible, submandibular saliva was fractionated by anion-exchange chromatography. Protein fractions containing anti-HIV activity were assayed for their ability to strip gp120 from virus. The partially purified active fractions contained two high-molecular-weight sialyated glycoproteins identified as salivary agglutinin and mucin, as well as several lower-molecular-weight proteins. It thus appears that specific salivary proteins interact with HIV-1 to strip gp120 from the virus with a resultant decrease in infectivity.

Original languageEnglish (US)
Pages (from-to)1635-1641
Number of pages7
JournalJournal of Infectious Diseases
Volume178
Issue number6
DOIs
StatePublished - 1998

Fingerprint

Virus Diseases
Saliva
HIV-1
Glycoproteins
Salivary Proteins and Peptides
Viruses
Molecular Weight
Agglutinins
Mucins
Centrifugation
Anions
Sucrose
Chromatography
Proteins
HIV

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

Human submandibular saliva inhibits human immunodeficiency virus type 1 infection by displacing envelope glycoprotein gp120 from the virus. / Nagashunmugam, Thandavarayan; Malamud, Daniel; Davis, Cheryl; Abrams, William R.; Friedman, Harvey M.

In: Journal of Infectious Diseases, Vol. 178, No. 6, 1998, p. 1635-1641.

Research output: Contribution to journalArticle

Nagashunmugam, Thandavarayan ; Malamud, Daniel ; Davis, Cheryl ; Abrams, William R. ; Friedman, Harvey M. / Human submandibular saliva inhibits human immunodeficiency virus type 1 infection by displacing envelope glycoprotein gp120 from the virus. In: Journal of Infectious Diseases. 1998 ; Vol. 178, No. 6. pp. 1635-1641.
@article{995f68bbf26b455d86cc99d7b1352999,
title = "Human submandibular saliva inhibits human immunodeficiency virus type 1 infection by displacing envelope glycoprotein gp120 from the virus",
abstract = "Human submandibular saliva reduces human immunodeficiency virus type 1 (HIV-1) infection in vitro. To define the mechanism of inhibition, virus was incubated with saliva or medium, velocity sucrose gradient centrifugation was performed, and fractions were analyzed for p24 and gp120. The results show that after incubation with saliva, the envelope glycoprotein was displaced from both a laboratory-adapted and a low-passage clinical HIV-1 isolate. To identify the salivary protein(s) responsible, submandibular saliva was fractionated by anion-exchange chromatography. Protein fractions containing anti-HIV activity were assayed for their ability to strip gp120 from virus. The partially purified active fractions contained two high-molecular-weight sialyated glycoproteins identified as salivary agglutinin and mucin, as well as several lower-molecular-weight proteins. It thus appears that specific salivary proteins interact with HIV-1 to strip gp120 from the virus with a resultant decrease in infectivity.",
author = "Thandavarayan Nagashunmugam and Daniel Malamud and Cheryl Davis and Abrams, {William R.} and Friedman, {Harvey M.}",
year = "1998",
doi = "10.1086/314511",
language = "English (US)",
volume = "178",
pages = "1635--1641",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Human submandibular saliva inhibits human immunodeficiency virus type 1 infection by displacing envelope glycoprotein gp120 from the virus

AU - Nagashunmugam, Thandavarayan

AU - Malamud, Daniel

AU - Davis, Cheryl

AU - Abrams, William R.

AU - Friedman, Harvey M.

PY - 1998

Y1 - 1998

N2 - Human submandibular saliva reduces human immunodeficiency virus type 1 (HIV-1) infection in vitro. To define the mechanism of inhibition, virus was incubated with saliva or medium, velocity sucrose gradient centrifugation was performed, and fractions were analyzed for p24 and gp120. The results show that after incubation with saliva, the envelope glycoprotein was displaced from both a laboratory-adapted and a low-passage clinical HIV-1 isolate. To identify the salivary protein(s) responsible, submandibular saliva was fractionated by anion-exchange chromatography. Protein fractions containing anti-HIV activity were assayed for their ability to strip gp120 from virus. The partially purified active fractions contained two high-molecular-weight sialyated glycoproteins identified as salivary agglutinin and mucin, as well as several lower-molecular-weight proteins. It thus appears that specific salivary proteins interact with HIV-1 to strip gp120 from the virus with a resultant decrease in infectivity.

AB - Human submandibular saliva reduces human immunodeficiency virus type 1 (HIV-1) infection in vitro. To define the mechanism of inhibition, virus was incubated with saliva or medium, velocity sucrose gradient centrifugation was performed, and fractions were analyzed for p24 and gp120. The results show that after incubation with saliva, the envelope glycoprotein was displaced from both a laboratory-adapted and a low-passage clinical HIV-1 isolate. To identify the salivary protein(s) responsible, submandibular saliva was fractionated by anion-exchange chromatography. Protein fractions containing anti-HIV activity were assayed for their ability to strip gp120 from virus. The partially purified active fractions contained two high-molecular-weight sialyated glycoproteins identified as salivary agglutinin and mucin, as well as several lower-molecular-weight proteins. It thus appears that specific salivary proteins interact with HIV-1 to strip gp120 from the virus with a resultant decrease in infectivity.

UR - http://www.scopus.com/inward/record.url?scp=0031766129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031766129&partnerID=8YFLogxK

U2 - 10.1086/314511

DO - 10.1086/314511

M3 - Article

C2 - 9815215

AN - SCOPUS:0031766129

VL - 178

SP - 1635

EP - 1641

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 6

ER -